These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 17965484)

  • 1. Impact of lipid-lowering therapy with pitavastatin, a new HMG-CoA reductase inhibitor, on regression of coronary atherosclerotic plaque.
    Takashima H; Ozaki Y; Yasukawa T; Waseda K; Asai K; Wakita Y; Kuroda Y; Kosaka T; Kuhara Y; Ito T
    Circ J; 2007 Nov; 71(11):1678-84. PubMed ID: 17965484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter-IVUS.
    Hattori K; Ozaki Y; Ismail TF; Okumura M; Naruse H; Kan S; Ishikawa M; Kawai T; Ohta M; Kawai H; Hashimoto T; Takagi Y; Ishii J; Serruys PW; Narula J
    JACC Cardiovasc Imaging; 2012 Feb; 5(2):169-77. PubMed ID: 22340823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy of eicosapentaenoic acid and pitavastatin for coronary plaque regression evaluated by integrated backscatter intravascular ultrasonography (CHERRY study)-rationale and design.
    Watanabe T; Miyamoto T; Miyasita T; Shishido T; Arimoto T; Takahashi H; Nishiyama S; Hirono O; Matsui M; Sugawara S; Ikeno E; Miyawaki H; Akira F; Kubota I
    J Cardiol; 2014 Sep; 64(3):236-9. PubMed ID: 24503140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
    Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
    Schoenhagen P; Tuzcu EM; Apperson-Hansen C; Wang C; Wolski K; Lin S; Sipahi I; Nicholls SJ; Magyar WA; Loyd A; Churchill T; Crowe T; Nissen SE
    Circulation; 2006 Jun; 113(24):2826-34. PubMed ID: 16769916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plaque REgression with Cholesterol absorption Inhibitor or Synthesis inhibitor Evaluated by IntraVascular UltraSound (PRECISE-IVUS Trial): Study protocol for a randomized controlled trial.
    Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Ono T; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
    J Cardiol; 2015 Oct; 66(4):353-8. PubMed ID: 25577723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
    Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
    Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization and regression of coronary plaques treated with pitavastatin proven by angioscopy and intravascular ultrasound--the TOGETHAR trial.
    Kodama K; Komatsu S; Ueda Y; Takayama T; Yajima J; Nanto S; Matsuoka H; Saito S; Hirayama A
    Circ J; 2010 Sep; 74(9):1922-8. PubMed ID: 20625215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time course of statin-induced changes in coronary atherosclerosis using intravascular ultrasound with virtual histology.
    Nozue T; Fukui K; Yamamoto S; Kunishima T; Umezawa S; Onishi Y; Tohyama S; Hibi K; Sozu T; Terashima M; Michishita I;
    Coron Artery Dis; 2013 Sep; 24(6):481-6. PubMed ID: 23751736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early effect of lipid-lowering therapy with pitavastatin on regression of coronary atherosclerotic plaque. Comparison with atorvastatin.
    Toi T; Taguchi I; Yoneda S; Kageyama M; Kikuchi A; Tokura M; Kanaya T; Abe S; Matsuda R; Kaneko N
    Circ J; 2009 Aug; 73(8):1466-72. PubMed ID: 19531899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.
    Arai H; Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Atheroscler Thromb; 2010 Oct; 17(10):1096-107. PubMed ID: 20675955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Circ J; 2010 Jun; 74(6):1165-74. PubMed ID: 20467151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin treatment for coronary artery plaque composition based on intravascular ultrasound radiofrequency data analysis.
    Nozue T; Yamamoto S; Tohyama S; Umezawa S; Kunishima T; Sato A; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Sozu T; Terashima M; Michishita I
    Am Heart J; 2012 Feb; 163(2):191-9.e1. PubMed ID: 22305836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of fluvastatin on progression of coronary atherosclerotic plaque evaluated by virtual histology intravascular ultrasound.
    Nasu K; Tsuchikane E; Katoh O; Tanaka N; Kimura M; Ehara M; Kinoshita Y; Matsubara T; Matsuo H; Asakura K; Asakura Y; Terashima M; Takayama T; Honye J; Hirayama A; Saito S; Suzuki T
    JACC Cardiovasc Interv; 2009 Jul; 2(7):689-96. PubMed ID: 19628194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study.
    Ohashi T; Shibata R; Morimoto T; Kanashiro M; Ishii H; Ichimiya S; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura T; Daida H; Murohara T; Matsuzaki M
    Atherosclerosis; 2010 Sep; 212(1):237-42. PubMed ID: 20684825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clustering of metabolic syndrome components attenuates coronary plaque regression during intensive statin therapy in patients with acute coronary syndrome: the JAPAN-ACS subanalysis study.
    Takashima H; Ozaki Y; Morimoto T; Kimura T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Daida H; Mizuno T; Asai K; Kuroda Y; Kosaka T; Kuhara Y; Kurita A; Maeda K; Amano T; Matsuzaki M;
    Circ J; 2012; 76(12):2840-7. PubMed ID: 22972364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.